For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later lung cancer risk. Learn how to protect yourself.
Inside a mobile lab, Our Lady of the Lake Regional Medical Center is showcasing the robotic technology its surgeons and doctors are using to detect and treat lung cancer.
A newly released publication examines how deuterium concentration may influence gene activity in lung cancer cells. The study explores how shifts in this ...
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...
A UVA Health study finds severe viral infections can prime the lungs for cancer, but vaccination appears to reduce that risk.
Mel McLaughlin revealed her stage 2 lung cancer diagnosis after a recent absence from her role as a sports broadcaster The ...
The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with cancer, the growing ...
The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...
Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, metastatic, non-squamous, non-small cell lung cancer ...